| Code | Description | Claims | Beneficiaries | Total Paid |
| J2315 |
Injection, naltrexone, depot form, 1 mg |
1,932 |
1,299 |
$982K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,744 |
12,378 |
$812K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,896 |
2,347 |
$233K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,563 |
2,862 |
$117K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,602 |
1,318 |
$100K |
| 96160 |
|
6,134 |
4,141 |
$59K |
| 81025 |
|
10,326 |
7,264 |
$43K |
| 99406 |
|
6,603 |
4,764 |
$41K |
| 80305 |
|
7,237 |
5,094 |
$36K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
4,333 |
3,470 |
$32K |
| 93000 |
|
2,760 |
2,202 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,823 |
1,799 |
$30K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
507 |
424 |
$30K |
| 94010 |
|
1,533 |
1,240 |
$30K |
| 99401 |
|
1,963 |
1,412 |
$27K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
3,296 |
2,739 |
$17K |
| 81002 |
|
7,492 |
5,594 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
393 |
319 |
$13K |
| G0397 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes |
417 |
302 |
$11K |
| 99408 |
|
681 |
464 |
$11K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
72 |
66 |
$8K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
320 |
260 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
3,299 |
2,404 |
$5K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
360 |
301 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
100 |
78 |
$3K |
| 90674 |
|
142 |
110 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
31 |
29 |
$2K |
| 3008F |
|
720 |
577 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
121 |
92 |
$2K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
60 |
41 |
$2K |
| 99173 |
|
346 |
310 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
206 |
149 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14 |
14 |
$1K |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
63 |
40 |
$977.39 |
| 90686 |
|
151 |
131 |
$952.60 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
22 |
18 |
$923.06 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
38 |
27 |
$770.52 |
| 99326 |
|
21 |
14 |
$544.12 |
| 90688 |
|
38 |
32 |
$539.23 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
44 |
36 |
$422.32 |
| 90685 |
|
36 |
26 |
$327.43 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
32 |
27 |
$303.14 |
| 87210 |
|
94 |
82 |
$241.83 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
178 |
118 |
$221.20 |
| 98960 |
|
13 |
12 |
$115.69 |
| 82948 |
|
49 |
43 |
$102.23 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
178 |
118 |
$60.71 |
| 82962 |
|
13 |
12 |
$31.72 |
| M1207 |
Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety |
494 |
428 |
$0.00 |
| 99000 |
|
52 |
42 |
$0.00 |
| 99072 |
|
22 |
18 |
$0.00 |